FDA Inspection 1160534 — Jawahar L. Taunk, M.D.
The FDA completed an inspection of Jawahar L. Taunk, M.D. on Dec 9, 2021 in Palm Harbor, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 9, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Palm Harbor, FL (United States)
Additional Details
Clinical Investigator (CI)